BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1274 related articles for article (PubMed ID: 19201770)

  • 1. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
    Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
    Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma miR-21: a potential diagnostic marker of colorectal cancer.
    Kanaan Z; Rai SN; Eichenberger MR; Roberts H; Keskey B; Pan J; Galandiuk S
    Ann Surg; 2012 Sep; 256(3):544-51. PubMed ID: 22868372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression profiling of exfoliated colonocytes isolated from feces for colorectal cancer screening.
    Koga Y; Yasunaga M; Takahashi A; Kuroda J; Moriya Y; Akasu T; Fujita S; Yamamoto S; Baba H; Matsumura Y
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1435-42. PubMed ID: 20959518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
    Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-150 as a potential biomarker associated with prognosis and therapeutic outcome in colorectal cancer.
    Ma Y; Zhang P; Wang F; Zhang H; Yang J; Peng J; Liu W; Qin H
    Gut; 2012 Oct; 61(10):1447-53. PubMed ID: 22052060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
    Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
    Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of miR-92a and miR-21 in stool samples as potential screening biomarkers for colorectal cancer and polyps.
    Wu CW; Ng SS; Dong YJ; Ng SC; Leung WW; Lee CW; Wong YN; Chan FK; Yu J; Sung JJ
    Gut; 2012 May; 61(5):739-45. PubMed ID: 21930727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and evaluation of a colorimetric membrane-array method for the detection of circulating tumor cells in the peripheral blood of Taiwanese patients with colorectal cancer.
    Wang JY; Yeh CS; Chen YF; Wu CH; Hsieh JS; Huang TJ; Huang SY; Lin SR
    Int J Mol Med; 2006 May; 17(5):737-47. PubMed ID: 16596255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA signatures: novel biomarker for colorectal cancer?
    Luo X; Burwinkel B; Tao S; Brenner H
    Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1272-86. PubMed ID: 21551242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.
    Pu XX; Huang GL; Guo HQ; Guo CC; Li H; Ye S; Ling S; Jiang L; Tian Y; Lin TY
    J Gastroenterol Hepatol; 2010 Oct; 25(10):1674-80. PubMed ID: 20880178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic identification and validation of candidate genes for detection of circulating tumor cells in peripheral blood specimens of colorectal cancer patients.
    Findeisen P; Röckel M; Nees M; Röder C; Kienle P; Von Knebel Doeberitz M; Kalthoff H; Neumaier M
    Int J Oncol; 2008 Nov; 33(5):1001-10. PubMed ID: 18949363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer.
    Kanaan Z; Roberts H; Eichenberger MR; Billeter A; Ocheretner G; Pan J; Rai SN; Jorden J; Williford A; Galandiuk S
    Ann Surg; 2013 Sep; 258(3):400-8. PubMed ID: 24022433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological significance of microRNA-21 and miR-125 expression in colorectal cancer].
    Zhang Y; Zhou ZG; Wang L; Zhang P; Wang MJ; Cui CF; Guan JT; Chen KL; Zhan L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):623-6. PubMed ID: 19921579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical potential role of circulating microRNAs in early diagnosis of colorectal cancer patients.
    Du M; Liu S; Gu D; Wang Q; Zhu L; Kang M; Shi D; Chu H; Tong N; Chen J; Adams TS; Zhang Z; Wang M
    Carcinogenesis; 2014 Dec; 35(12):2723-30. PubMed ID: 25239640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease.
    Terrin L; Rampazzo E; Pucciarelli S; Agostini M; Bertorelle R; Esposito G; DelBianco P; Nitti D; De Rossi A
    Clin Cancer Res; 2008 Nov; 14(22):7444-51. PubMed ID: 19010861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of fecal miR-143 and miR-145 as potential markers for colorectal cancer.
    Li JM; Zhao RH; Li ST; Xie CX; Jiang HH; Ding WJ; Du P; Chen W; Yang M; Cui L
    Saudi Med J; 2012 Jan; 33(1):24-9. PubMed ID: 22273643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
    Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
    Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer.
    Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S397-405. PubMed ID: 22956063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study.
    Giráldez MD; Lozano JJ; Ramírez G; Hijona E; Bujanda L; Castells A; Gironella M
    Clin Gastroenterol Hepatol; 2013 Jun; 11(6):681-8.e3. PubMed ID: 23267864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.